losartan has been researched along with kallidin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campbell, DJ; Esler, MD; Krum, H | 1 |
| Cruden, NL; Fox, KA; Ludlam, CA; Megson, I; Newby, DE; Tse, GH | 1 |
2 trial(s) available for losartan and kallidin
| Article | Year |
|---|---|
Losartan increases bradykinin levels in hypertensive humans.
Topics: Acrylates; Adolescent; Adult; Aged; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Bradykinin; Chromatography, High Pressure Liquid; Cross-Over Studies; Double-Blind Method; Female; Humans; Hydroxylation; Hypertension; Imidazoles; Kallidin; Losartan; Male; Middle Aged; Peptide Fragments; Radioimmunoassay; Thiophenes | 2005 |
B1 kinin receptor does not contribute to vascular tone or tissue plasminogen activator release in the peripheral circulation of patients with heart failure.
Topics: Adolescent; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bradykinin B1 Receptor Antagonists; Cross-Over Studies; Enalapril; Female; Fibrinolysis; Forearm; Heart Failure; Humans; In Vitro Techniques; Kallidin; Losartan; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Pregnancy; Receptor, Bradykinin B1; Regional Blood Flow; Tissue Plasminogen Activator; Umbilical Veins; Vasoconstriction | 2005 |